Riskpilot← Back to searchSign inGet full accessRahl Med AB
ABActiveOrg 5591852230Karlavägen 8Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 359K
-11% vs 2024
EBITDA margin
52.0%
-39% vs 2024
Equity ratio
88.3%
Financial strength
Net profit 2025
SEK 496K
+108% vs 2024
| Revenue | SEK 359K | -11% |
| EBITDA | SEK 187K | -39% |
| Net profit | SEK 496K | +108% |
| Total assets | SEK 1,2M | +38% |
| Equity | SEK 1,1M | +37% |
| Employees | 1 | — |
Legal name
Rahl Med AB
Org number
5591852230
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 december 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinsk verksamhet och konsultverksamhet inom hälso och sjukvård. Utbildningar och föreläsningar inom medicin, hälsa, ledarskap samt närliggande områden. Kurs och eventarrangör. Köp och försäljning av värdepapper.
Address
Karlavägen 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 359 | 823 | 499 | 403 | 359 |
| Staff expenses | — | −15 | −12 | −17 | −27 |
| EBITDA | 302 | 747 | 441 | 304 | 187 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 302 | 747 | 441 | 304 | 187 |
| Net financials | −2 | −1 | 1 | 1 | 43 |
| Profit before tax | 301 | 746 | 442 | 305 | 620 |
| Tax | −63 | −155 | −92 | −66 | −124 |
| Net profit | 238 | 591 | 351 | 239 | 496 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 544 | 1 129 | 1 004 | 873 | 1 208 |
| Equity | 376 | 779 | 747 | 781 | 1 067 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 168 | 349 | 257 | 92 | 141 |
| Total debt | 168 | 349 | 257 | 92 | 141 |
EBITDA margin
52.0%
This company
15.8%
Market median
+229% vs market
20212025
Equity ratio
88.3%
This company
38.2%
Market median
+131% vs market
20212025
Return on equity
46.5%
This company
18.4%
Market median
+153% vs market
20212025
Net profit margin
138.0%
This company
8.1%
Market median
+1604% vs market
20212025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rahl Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Markus Kristofer Rahl | Board of Directors | 0 companies |
| Elisabet Ebba Charlotta Rahl | Deputy Board Member | 0 companies |